1 2 Figure S1. Forest plots of overall eradication rates between PAM therapy and PAC therapy in all 3 eligible trials in intention-to-treat analysis (A) and in per-protocol analysis (B) in the fixed-effects 4 model. Abbreviations: CI, confidence interval; PAC, proton pump 5 inhibitor/amoxicillin/clarithromycin; PAM, proton pump inhibitor/amoxicillin/metronidazole. 6 J. Clin. Med. 2020, 9, 543 2 of 5 7 Figure S2. (A) Forest plots of eradication rates between PAM therapy and PAC therapy in areas 8 classified as having low CAM resistance (< 15%) and high MNZ resistance (≥ 15%), (B) high CAM 9 resistance and low MNZ resistance, and (C) high CAM resistance and high MNZ resistance in 10 intention-to-treat analysis in the fixed-effects model. Abbreviations: CAM, clarithromycin; CI, 11 confidence interval; MNZ, metronidazole; PAC, proton pump inhibitor/amoxicillin/clarithromycin; 12 PAM, proton pump inhibitor/amoxicillin/metronidazole. 13
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